Data / Drug companies / BioComp Pharma, Inc.
BioComp Pharma, Inc.: 28 products in the FDA NDC directory, labeler code 44523
BioComp Pharma, Inc. (labeler code 44523) lists 28 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 28 prescription drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on September 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 44523
- Products in commercial distribution
- 28
- Packages
- 34
- Finished drugs by generic name
- 13
- Prescription products
- 28
- Over the counter products
- 0
- Flagged as original packager
- 28 of 28 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- April 15, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 19 | 67.9% |
| Authorized generics (NDA) | 6 | 21.4% |
| Generic drugs (ANDA) | 3 | 10.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 28 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Sulfacetamide sodium, sulfur | 9 | 13 |
| Sodium sulfacetamide | 3 | 10 |
| Tiopronin | 3 | 8 |
| Sulfacetamide sodium | 2 | 13 |
| Urea | 2 | 17 |
| Potassium citrate | 2 | 17 |
| Sodium sulfacetamide, sulfur | 1 | 4 |
| Carbinoxamine maleate | 1 | 9 |
| Gabapentin | 1 | 91 |
| Tinidazole | 1 | 7 |
| Sodium sulfacetamide 9.8% and sulfur 4.8% | 1 | 1 |
| Urea 39% cream | 1 | 1 |
| Prednisolone sodium phosphate | 1 | 16 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 6 | 21.4% |
| Lotion | 4 | 14.3% |
| Emulsion | 3 | 10.7% |
| Liquid | 3 | 10.7% |
| Tablet | 3 | 10.7% |
| Tablet, delayed release | 2 | 7.1% |
| Suspension | 2 | 7.1% |
| Solution | 2 | 7.1% |
| Tablet, sugar coated | 1 | 3.6% |
| Tablet, film coated | 1 | 3.6% |
| Shampoo | 1 | 3.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Sulfonamide Antibacterial | 16 |
| Reducing and Complexing Thiol | 3 |
| Anti-coagulant | 2 |
| Calculi Dissolution Agent | 2 |
| Histamine-1 Receptor Antagonist | 1 |
| Nitroimidazole Antimicrobial | 1 |
| Corticosteroid | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tiopronin | 44523-053 | Tablet, sugar coated | Authorized generics (NDA) | September 1, 2026 |
| Tinidazole | 44523-450 | Tablet, film coated | Authorized generics (NDA) | March 20, 2025 |
| Sodium sulfacetamide and sulfur | 44523-624 | Suspension | Other unapproved drugs | January 27, 2025 |
| Sodium sulfacetamide and sulfur | 44523-600 | Lotion | Other unapproved drugs | January 23, 2025 |
| Sodium sulfacetamide and sulfur | 44523-748 | Emulsion | Other unapproved drugs | December 17, 2024 |
| Tiopronin | 44523-055 | Tablet, delayed release | Authorized generics (NDA) | December 5, 2024 |
| Tiopronin | 44523-054 | Tablet, delayed release | Authorized generics (NDA) | December 5, 2024 |
| Potassium Citrate | 44523-410 | Tablet | Authorized generics (NDA) | December 3, 2024 |
| Urea | 44523-618 | Cream | Other unapproved drugs | February 15, 2024 |
| Gabapentin | 44523-120 | Solution | Generic drugs (ANDA) | November 30, 2023 |
| Urea 39% Cream | 44523-801 | Cream | Other unapproved drugs | September 23, 2022 |
| Prednisolone Sodium Phosphate Oral Solution | 44523-182 | Solution | Generic drugs (ANDA) | October 28, 2019 |
| Urea | 44523-617 | Cream | Other unapproved drugs | March 15, 2018 |
| Potassium Citrate | 44523-415 | Tablet | Authorized generics (NDA) | December 23, 2013 |
| Sodium sulfacetamide | 44523-606 | Liquid | Other unapproved drugs | January 7, 2013 |
| Sulfacetamide sodium | 44523-568 | Liquid | Other unapproved drugs | September 15, 2011 |
| Sulfacetamide sodium, sulfur | 44523-560 | Emulsion | Other unapproved drugs | September 15, 2011 |
| Sodium Sulfacetamide, Sulfur | 44523-550 | Emulsion | Other unapproved drugs | September 15, 2011 |
| Sodium Sulfacetamide, Sulfur | 44523-542 | Cream | Other unapproved drugs | September 15, 2011 |
| Sodium Sulfacetamide, Sulfur | 44523-520 | Cream | Other unapproved drugs | September 15, 2011 |
| Sodium Sulfacetamide | 44523-510 | Shampoo | Other unapproved drugs | September 15, 2011 |
| Sodium sulfacetamide | 44523-613 | Liquid | Other unapproved drugs | September 7, 2011 |
| Sodium sulfacetamide and sulfur | 44523-607 | Lotion | Other unapproved drugs | June 4, 2011 |
| Sodium sulfacetamide, sulfur | 44523-604 | Suspension | Other unapproved drugs | June 4, 2011 |
| Carbinoxamine Maleate | 44523-825 | Tablet | Generic drugs (ANDA) | May 27, 2011 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.